Biotechnology Two sick children and a $1.5 million bill: One family’s race for a gene therapy cure One day, gene therapy may help with the rarest of diseases. Some parents aren’t waiting. by Antonio Regalado 2018-10-23T05:00:00-04:00
Rewriting Life Digital Pills Track How Patients Use Opioids Ingestible sensors could help doctors keep people from becoming addicted to prescription painkillers. by Emily Mullin 2017-12-11T17:06:00-05:00
Biotechnology Biohackers Disregard FDA Warning on DIY Gene Therapy The agency seeks a crackdown on companies offering kits to produce gene therapies for self-administration. by Emily Mullin 2017-12-01T10:00:00-05:00
Rewriting Life Female Viagra Is Found Lacking as “Predatory” Drugmaker Valeant Falls Further The drug company has earned the ire of Hillary Clinton, is under several investigations, and was met with a collective “meh” from women who tried its “female Viagra” pill. by Antonio Regalado 2016-03-01T16:32:00-05:00
Biotechnology The Anti-Aging Pill Facing a long wait for evidence, a longevity researcher takes an unusual path to market. by Karen Weintraub 2015-02-03T05:00:00-05:00
Business Impact 23andMe Tries to Woo the FDA The DNA testing firm hopes a more coöperative approach with regulators will get its business back on track. by Robert D. Hof 2014-07-21T12:00:00-04:00
Rewriting Life A Tale of Two Drugs Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system. by Barry Werth 2013-10-22T02:00:00-04:00